Doug Arm

Company: EV Therapeutics

Job title: Chief Operating Officer

Seminars:

Strategic Development of a Native Extracellular Vesicle Platform Technology for Regenerative Medicine Therapeutic Applications 1:30 pm

EV Therapeutics has broadened our portfolio to include a novel, native EV technology, synergistic with our modified EV therapeutic platform This platform technology has strong MOA data and is supported by positive clinical use data outside the USA Prioritizing this native EV technology enables EV Therapeutics to chart a more rapid path towards clinical trials…Read more

day: Conference Day Two